Ads
related to: therapy notes software
Search results
Myriad Genetics (NASDAQ:MYGN) Hits New 52-Week High at $24.92
ETF DAILY NEWS· 5 hours agoMyriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report)’s stock price hit a new 52-week high during mid-day trading on Thursday . The company traded as high as $24.92 and last traded at $24.45 ...
TransMedics Group, Inc. (NASDAQ:TMDX) Insider Sells $418,570.02 in Stock
ETF DAILY NEWS· 6 hours agoTransMedics Group, Inc. (NASDAQ:TMDX – Get Free Report) insider Nicholas Corcoran sold 3,222 shares of the business’s stock in a transaction that occurred on Monday, May 6th. The shares were ...
Benjamin F. Edwards & Company Inc. Buys New Stake in The Ensign Group, Inc. (NASDAQ:ENSG)
ETF DAILY NEWS· 6 hours agoBenjamin F. Edwards & Company Inc. purchased a new position in shares of The Ensign Group, Inc. (NASDAQ:ENSG – Free Report) in the fourth quarter, according to its most recent disclosure with ...
Swiss National Bank Sells 21,600 Shares of Tenet Healthcare Co. (NYSE:THC)
ETF DAILY NEWS· 6 hours agoSwiss National Bank lowered its holdings in shares of Tenet Healthcare Co. (NYSE:THC – Free Report) by 10.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities ...
National Bank of Canada FI Boosts Stake in Tenet Healthcare Co. (NYSE:THC)
ETF DAILY NEWS· 5 hours agoNational Bank of Canada FI increased its holdings in Tenet Healthcare Co. (NYSE:THC – Free Report) by 267.1% in the 4th quarter, according to its most recent filing with the SEC. The institutional ...
Nuwellis Inc (NUWE) Q1 2024 Earnings Call Transcript Highlights:
Guru Focus· 4 days agoRevenue: $1.9 million, a 2% increase year-over-year.Pediatric Revenue Growth: 40% increase, driven by a 54% rise in consumable utilization.Critical Care Revenu
uniQure’s (QURE) Buy Rating Reiterated at HC Wainwright
ETF DAILY NEWS· 10 hours agoHC Wainwright currently has a $25.00 target price on the biotechnology company’s stock. A number of other brokerages have also commented on QURE. Mizuho dropped their price target on uniQure ...
uniQure (NASDAQ:QURE) Forecasted to Earn Q2 2024 Earnings of ($1.16) Per Share
ETF DAILY NEWS· 9 hours agoWilliam Blair analyst S. Corwin now forecasts that the biotechnology company will earn ($1.16) per share for the quarter, down from their previous estimate of ($1.12). The consensus estimate ...
Correct Dx of Cancer Treatment Skin Effects Evaluated
Medscape· 5 days agoCompared with medical oncologists, dermatologists were more likely to correctly classify and grade dermatologic adverse events from cancer therapies, results from a multicenter survey showed ...
Arcus Biosciences (NYSE:RCUS) Shares Gap Up on Better-Than-Expected Earnings
ETF DAILY NEWS· 11 hours agoShares of Arcus Biosciences, Inc. (NYSE:RCUS – Get Free Report) gapped up before the market opened on Thursday following a stronger than expected earnings report. Arcus Biosciences shares last ...
Ads
related to: therapy notes software